[HTML][HTML] Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines at 12–24 …
Background The combination of whole-cell pertussis (wP) antigens with established
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …
diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b (Hib), and …
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in …
R Koepke, JC Eickhoff, RA Ayele… - The Journal of …, 2014 - academic.oup.com
Background. We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular
pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide …
pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide …
Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the …
S Schmitt-Grohé, K Stehr, JD Cherry… - Developments in …, 1997 - europepmc.org
Minor adverse events were evaluated in a comparative efficacy trial in Germany in infants
who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine …
who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine …
Rationale for use of Tdap booster vaccines for adolescent immunization: Overview of efficacy, safety, and clinical use
WP Hitchcock - Clinical pediatrics, 2006 - journals.sagepub.com
Pertussis is one of the only vaccine-preventable diseases with increasing incidence in the
United States. The incidence of pertussis infection in adolescents is a growing concern; it …
United States. The incidence of pertussis infection in adolescents is a growing concern; it …
Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus …
DP Greenberg, M Doemland, JA Bettinger… - The Pediatric …, 2009 - journals.lww.com
Background: During the decade 1998-2007, a combination DTaP 5-IPV/Hib vaccine was
used exclusively in Canada to immunize infants and young children against diphtheria …
used exclusively in Canada to immunize infants and young children against diphtheria …
Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5–6-year-old children after primary vaccination …
E Mallet, N Matisse, N Mathieu, J Langue, F Boisnard… - Vaccine, 2004 - Elsevier
The main objective of this study was to assess in 5–6-year-old French children (n= 234) the
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …
How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
SA Halperin, L Sweet, D Baxendale… - The Pediatric …, 2006 - journals.lww.com
Background: Adult formulation tetanus and diphtheria toxoids and acellular pertussis
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …
Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents
ME Pichichero, MM Blatter, WA Kennedy, J Hedrick… - …, 2006 - publications.aap.org
BACKGROUND. The incidence of pertussis is increasing, especially in adolescents,
attributed in part to waning of immunity after childhood immunization. Recently licensed in …
attributed in part to waning of immunity after childhood immunization. Recently licensed in …
A phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at two, three, four and twelve months
T Vesikari, T Becker, AF Vertruyen… - The Pediatric …, 2017 - journals.lww.com
Background: Combination vaccines simplify vaccination visits and improve coverage and
timeliness. Diphtheria–tetanus toxoids–acellular pertussis 5, hepatitis B, inactivated …
timeliness. Diphtheria–tetanus toxoids–acellular pertussis 5, hepatitis B, inactivated …